PT - JOURNAL ARTICLE AU - Vasconcelos, Alexandra AU - Sousa, Swasilanne AU - Bandeira, Nelson AU - Alves, Marta AU - Papoila, Ana Luísa AU - Pereira, Filomena AU - Machado, Maria Céu TI - Factors associated with peri-neonatal mortality in Sao Tome & Principe: a prospective cohort study AID - 10.1101/2022.08.07.22278476 DP - 2023 Jan 01 TA - medRxiv PG - 2022.08.07.22278476 4099 - http://medrxiv.org/content/early/2023/04/03/2022.08.07.22278476.short 4100 - http://medrxiv.org/content/early/2023/04/03/2022.08.07.22278476.full AB - Background Neonatal mortality reduction is a global goal but its factors in high-burden nations vary and are poorly understood. This study was conducted to identify the factors affecting peri- neonatal mortality in Sao Tome & Principe (STP), one of the smallest African countries.Methods Institution-based prospective cohort study conducted at Hospital Dr. Ayres Menezes. Maternal-neonate dyads enrolled were followed up after the 28th day of life (n=194) for identification of neonatal death-outcome (n=22) and alive-outcome groups (n=172). Data were collected from pregnancy cards, hospital records and face-to-face interviews. After the 28th day of birth, a phone call was made to evaluate the newborn’s health status. A logistic regression model was used to identify the relevant factors associated with mortality, a p value <0.05 was considered statistically significant.Results The mean gestational age of the death-outcome and alive-outcome groups was 36 (SD=4.8) and 39 (SD=1.4) weeks, respectively. Death-outcome group (n=22) included sixteen stillbirths, four early and two late neonatal deaths. High-risk pregnancy score [cOR 2.91, 95%CI:1.18-7.22], meconium-stained fluid [cOR 4.38, 95%CI:1.74–10.98], prolonged rupture of membranes [cOR 4.84, 95%CI:1.47–15.93], transfer from another unit [cOR 6.08, 95%CI:1.95–18.90], and instrumental vaginal delivery [cOR 8.90, 95%CI:1.68–47.21], were factors significantly associated with mortality. The odds of experiencing death were higher for newborns with infectious risk, IUGR, resuscitation maneuvers, fetal distress at birth, birth asphyxia, and unit care admission. Female newborn [cOR 0.37, 95%CI:0.14-1.00] and birth weight of more than 2500 g [cOR 0.017, 95%CI:0.002-0.162] were found to be protective factors. In the multivariable model, meconium-stained fluid was significantly associated with death outcome.Conclusion Factors such as having a high-risk pregnancy score, meconium-stained amniotic fluid, prolonged rupture of membranes, being transferred from another unit, and an instrumental- assisted vaginal delivery increased 4– to 9–fold the risk of stillbirth and neonatal death. Of the factors associated with peri-neonatal mortality in this study, avoiding health-worker- related factors associated with delays in prompt intrapartum care is a key strategy to implement in Sao Tome & Principe.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAV was supported by the Fundação para a Ciência e Tecnologia (FCT) (https://www.fct.pt/index.phtml.pt/), grant number SFRH/BD/117037/2016. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ministry of Health of Sao Tome & Principe and the main board of the Hospital Dr. Ayres de Menezes are dedicated ethics oversight bodies, and both approved this studyI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.